Riskpilot← Back to searchSign inGet full accessAsadiMed AB
ABIn liquidationOrg 5592583503General medical practice activities · NACE 8621Est. 20200 employees
Revenue 2023
SEK 0
EBITDA margin
—
-765% vs 2022
Equity ratio
66.7%
Financial strength
Net profit 2023
SEK -13K
-765% vs 2022
| Revenue | SEK 0 | — |
| EBITDA | SEK -13K | -765% |
| Net profit | SEK -13K | -765% |
| Total assets | SEK 23K | -6% |
| Equity | SEK 15K | +12% |
| Employees | 0 | — |
Legal name
AsadiMed AB
Org number
5592583503
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
4 juni 2020
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av likvidatorn likvidatorsuppleanten
Company purpose
Bolaget ska bedriva konsultverksamhet, utveckling, rådgivning och utbildning inom medicin, hälso- och sjukvård. Därutöver skall bolaget bedriva handel med aktier och värdepapper.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | −0 | −0 |
| EBITDA | — | −10 | −2 | −13 |
| Depreciation & amort. | −0 | −0 | — | — |
| EBIT | 0 | −10 | −2 | −13 |
| Net financials | — | — | — | — |
| Profit before tax | 0 | −10 | −2 | −13 |
| Tax | −0 | −0 | — | — |
| Net profit | 0 | −10 | −2 | −13 |
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Total assets | 25 | 25 | 24 | 23 |
| Equity | 25 | 15 | 14 | 15 |
| Long-term debt | 0 | 0 | — | — |
| Short-term debt | 0 | 10 | 11 | 8 |
| Total debt | — | 10 | 11 | 8 |
EBITDA margin
-1337200.0%
This company
15.8%
Market median
-8463391% vs market
20202023
Equity ratio
66.7%
This company
38.2%
Market median
+75% vs market
20202023
Return on equity
-87.2%
This company
18.4%
Market median
-574% vs market
20202023
Net profit margin
-1337200.0%
This company
8.1%
Market median
-16508742% vs market
20202023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202023
Debt / equity
0.50×
This company
0.62×
Market median
+19% vs market
20202023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-06-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MW Liquidator | Liquidator | 2024 | — | — |
TL Liquidator | Liquidator | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AsadiMed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mikael Wiklund | Liquidator | 0 companies |
| Therese Louise Lidén | Liquidator | 0 companies |
| Hamid Reza Asadi | Board of Directors | 0 companies |
| Matilda Anna Helena Wässman Asadi | Deputy Board Member | 0 companies |